Upon the Tightrope in Prostate Cancer: Two Acrobats on the Same Tightrope to Cross the Finishline

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2011 Dec 28

PMID 22200977

Citations 1

Authors

Ammad Ahmad Farooqi

Sundas Fayyaz

Sadia Rashid

Affiliations

Soon will be listed here.

Abstract

Prostate cancer is a multifactorial, multistep progressive disorder that is undruggable to date because of stumbling blocks in the standardization of therapy. It is triggered by a broad range of proteins, signaling networks and DNA damage response modulators. It is becoming increasingly apparent that DNA repair mediators have split personalities, as they are instrumental in suppressing and promoting carcinogenesis. In this article, we discuss on post-transcriptional processing of regulators of DNA damage response, and how DNA repair proteins trigger shuttling of androgen receptor. Substantial fraction of information has been added into the existing literature of ATM biology; however, the particular area of post-transcriptional processing errors and gene therapy for reprogramming of ATM has been left unaddressed in prostate cancer. It is therefore noteworthy that the facet of targeting strategy, antisense morpholino oligonucleotides chemistry, and systematic delivery of AOs has promising outlook in splice-targeted antisense-mediated therapy.

Citing Articles

Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties.

Lee J, Hou M, Huang H, Chang F, Yeh C, Tang J Cancer Cell Int. 2013; 13(1):55.

PMID: 23724847 PMC: 3674937. DOI: 10.1186/1475-2867-13-55.

References

Mukhopadhyay U, Senderowicz A, Ferbeyre G . RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells. Cancer Res. 2005; 65(7):2872-81. DOI: 10.1158/0008-5472.CAN-04-2502. View

Bhatti S, Kozlov S, Farooqi A, Naqi A, Lavin M, Khanna K . ATM protein kinase: the linchpin of cellular defenses to stress. Cell Mol Life Sci. 2011; 68(18):2977-3006. PMC: 11115042. DOI: 10.1007/s00018-011-0683-9. View

Dombernowsky S, Weischer M, Allin K, Bojesen S, Tybjaerg-Hansen A, Nordestgaard B . Risk of cancer by ATM missense mutations in the general population. J Clin Oncol. 2008; 26(18):3057-62. DOI: 10.1200/JCO.2007.14.6613. View

Meyer A, Wilhelm B, Dork T, Bremer M, Baumann R, Karstens J . ATM missense variant P1054R predisposes to prostate cancer. Radiother Oncol. 2007; 83(3):283-8. DOI: 10.1016/j.radonc.2007.04.029. View

Agarwal C, Tyagi A, Agarwal R . Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells. Mol Cancer Ther. 2006; 5(12):3294-302. DOI: 10.1158/1535-7163.MCT-06-0483. View

Katzenberger R, Marengo M, Wassarman D . Control of alternative splicing by signal-dependent degradation of splicing-regulatory proteins. J Biol Chem. 2009; 284(16):10737-46. PMC: 2667761. DOI: 10.1074/jbc.M809506200. View

Shank L, Kelley J, Gioeli D, Yang C, Spencer A, Allison L . Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro. J Biol Chem. 2008; 283(16):10568-80. PMC: 7486792. DOI: 10.1074/jbc.M800810200. View

Cuffe S, Dowling C, Claffey J, Pampillon C, Hogan M, Fitzpatrick J . Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis. Prostate. 2010; 71(2):111-24. DOI: 10.1002/pros.21227. View

Marengo M, Wassarman D . A DNA damage signal activates and derepresses exon inclusion in Drosophila TAF1 alternative splicing. RNA. 2008; 14(8):1681-95. PMC: 2491473. DOI: 10.1261/rna.1048808. View

10.

Fan Z, Chakravarty P, Alfieri A, Pandita T, Vikram B, Guha C . Adenovirus-mediated antisense ATM gene transfer sensitizes prostate cancer cells to radiation. Cancer Gene Ther. 2000; 7(10):1307-14. DOI: 10.1038/sj.cgt.7700242. View

11.

Truman J, Rotenberg S, Kang J, Lerman G, Fuks Z, Kolesnick R . PKCalpha activation downregulates ATM and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo. Cancer Biol Ther. 2008; 8(1):54-63. PMC: 3630174. DOI: 10.4161/cbt.8.1.7119. View

12.

Rashid A, Liu C, Sanli T, Tsiani E, Singh G, Bristow R . Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways. Radiat Oncol. 2011; 6:144. PMC: 3217881. DOI: 10.1186/1748-717X-6-144. View

13.

Truman J, Gueven N, Lavin M, Leibel S, Kolesnick R, Fuks Z . Down-regulation of ATM protein sensitizes human prostate cancer cells to radiation-induced apoptosis. J Biol Chem. 2005; 280(24):23262-72. PMC: 1855286. DOI: 10.1074/jbc.M503701200. View

14.

Sanz D, Acedo A, Infante M, Duran M, Perez-Cabornero L, Esteban-Cardenosa E . A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients. Clin Cancer Res. 2010; 16(6):1957-67. DOI: 10.1158/1078-0432.CCR-09-2564. View

15.

Du L, Kayali R, Bertoni C, Fike F, Hu H, Iversen P . Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum. Hum Mol Genet. 2011; 20(16):3151-60. PMC: 3140820. DOI: 10.1093/hmg/ddr217. View

16.

Schutz S, Cronauer M, Rinnab L . Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines. J Cell Biochem. 2010; 109(6):1192-200. DOI: 10.1002/jcb.22500. View

17.

Hall J, Marcel V, Bolin C, Fernet M, Tartier L, Vaslin L . The associations of sequence variants in DNA-repair and cell-cycle genes with cancer risk: genotype-phenotype correlations. Biochem Soc Trans. 2009; 37(Pt 3):527-33. DOI: 10.1042/BST0370527. View

18.

Fan C, Quan R, Feng X, Gillis A, He L, Matsumoto E . ATM activation is accompanied with earlier stages of prostate tumorigenesis. Biochim Biophys Acta. 2006; 1763(10):1090-7. DOI: 10.1016/j.bbamcr.2006.08.026. View

19.

Chen H, Chang F, Hsieh Y, Cheng Y, Hsieh K, Tsai L . A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species. Free Radic Biol Med. 2011; 50(9):1151-62. DOI: 10.1016/j.freeradbiomed.2011.01.015. View

20.

Pastor T, Pagani F . Interaction of hnRNPA1/A2 and DAZAP1 with an Alu-derived intronic splicing enhancer regulates ATM aberrant splicing. PLoS One. 2011; 6(8):e23349. PMC: 3152568. DOI: 10.1371/journal.pone.0023349. View